Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.62 USD | +2.13% | +0.47% | +49.17% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 13.19M | Capitalization | 1.61B |
---|---|---|---|---|---|
Net income 2024 * | -194M | Net income 2025 * | -216M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 122 x |
P/E ratio 2024 * |
-9.12
x | P/E ratio 2025 * |
-8.78
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.82% |
Latest transcript on Kura Oncology, Inc.
1 day | +3.67% | ||
1 week | -3.51% | ||
Current month | +0.43% | ||
1 month | -2.71% | ||
3 months | +48.87% | ||
6 months | +144.18% | ||
Current year | +47.22% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
CEO | Chief Executive Officer | 55 | 14-08-21 |
Stephen Dale
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-08-24 |
Kathleen Ford
COO | Chief Operating Officer | 77 | 19-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 21-06-02 |
Faheem Hasnain
BRD | Director/Board Member | 65 | 15-04-26 |
Thomas Malley
BRD | Director/Board Member | 55 | 15-10-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 21.48 | +1.46% | 144 704 |
24-03-27 | 21.17 | +3.67% | 654,368 |
24-03-26 | 20.42 | -2.72% | 778,369 |
24-03-25 | 20.99 | -1.92% | 482,551 |
24-03-22 | 21.4 | +0.23% | 1,112,373 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.22% | 1.61B | |
+2.56% | 108B | |
+10.02% | 104B | |
+8.12% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |